1,3,5-triaza-7-phosphaadamantane has been researched along with adamantane in 43 studies
| Studies (1,3,5-triaza-7-phosphaadamantane) | Trials (1,3,5-triaza-7-phosphaadamantane) | Recent Studies (post-2010) (1,3,5-triaza-7-phosphaadamantane) | Studies (adamantane) | Trials (adamantane) | Recent Studies (post-2010) (adamantane) |
|---|---|---|---|---|---|
| 44 | 0 | 33 | 3,449 | 360 | 1,790 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (20.93) | 29.6817 |
| 2010's | 30 (69.77) | 24.3611 |
| 2020's | 4 (9.30) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamo, A; Brescacin, L; Cocchietto, M; Delfino, R; Dyson, PJ; Geldbach, TJ; Laurenczy, G; Sava, G; Scolaro, C | 1 |
| Alidori, S; Gioia Lobbia, G; Lewis, JS; Papini, G; Pellei, M; Porchia, M; Refosco, F; Santini, C; Tisato, F | 1 |
| Erlandsson, M; Gonsalvi, L; Ienco, A; Peruzzini, M | 1 |
| Pombeiro, AJ; Smoleński, P | 1 |
| Cerrada, E; de Vos, D; Laguna, M; Mendía, A; Miranda, S; Mohr, F; Vergara, E | 1 |
| Gossens, C; Rothlisberger, U; Tavernelli, I | 1 |
| Charmier, MA; Guedes da Silva, MF; Mukhopadhyay, S; Pombeiro, AJ; Smoleński, P | 1 |
| Benetollo, F; Gandin, V; Marzano, C; Porchia, M; Refosco, F; Tisato, F | 1 |
| Bindoli, A; Casini, A; Cerrada, E; Dyson, PJ; Laguna, M; Rigobello, MP; Sorrentino, F; Vergara, E; Zava, O | 1 |
| Callear, SK; Casini, A; Dyson, PJ; Hursthouse, MB; Pfeffer, M; Rathnam, RP; Spencer, J; Velhanda, SK; Zava, O | 1 |
| Evans, DH; Glass, RS; Lichtenberger, DL; Nichol, GS; Vannucci, AK; Wang, S | 1 |
| Bippus, P; Jakupec, MA; Keppler, BK; Mohr, F; Skocic, M | 1 |
| Bergamini, P; Canella, A; Hajji, L; Romerosa, A; Saraiba-Bello, C; Segovia-Torrente, G; Serrano-Ruiz, M | 1 |
| Frost, BJ; Galloway, KD; Gingrich, PW; Huang, R; Weeden, JA | 1 |
| Bramucci, M; da Silva, MF; Lupidi, G; Marchetti, F; Martins, LM; Petrelli, D; Pettinari, C; Pombeiro, AJ; Quassinti, L; Smoleński, P; Vitali, LA | 1 |
| Bergamini, P; Campioni, M; Cortesi, R; Costenaro, A; Drechsler, M; Esposito, E; Marvelli, L; Pinotti, M; Ravani, L | 1 |
| Eads, K; Enow, RA; Frost, BJ; Krogstad, DA; Lee, WC; Sears, JM | 1 |
| Bramucci, M; Jaros, SW; Kirillov, AM; Kochel, A; Lupidi, G; Petrelli, D; Pettinari, C; Quassinti, L; Smoleński, P; Vitali, LA | 1 |
| Alegria, EC; Kuznetsov, ML; Martins, LM; Pombeiro, AJ; Smoleński, P | 1 |
| Cerrada, E; Fröhlich, N; Guerrero, E; Koenen, JM; Laguna, M; Lüttenberg, S; Mendía, A; Miranda, S; Mohr, F | 1 |
| Blunden, BM; Lu, H; Stenzel, MH | 1 |
| Atrián-Blasco, E; Cerrada, E; García-Moreno, E; Gascón, S; Laguna, M; Rodriguez-Yoldi, MJ | 1 |
| Bergamini, P; Ferretti, V; Fogagnolo, M; Marchi, A; Marvelli, L; Sforza, F | 1 |
| Badillo Patzmay, GV; Guedes da Silva, MF; Lupidi, G; Marchetti, F; Petrelli, D; Pettinari, C; Pombeiro, AJ; Smoleński, P; Vitali, LA | 1 |
| Atrián-Blasco, E; Cerrada, E; Conte-Daban, A; Faller, P; Hureau, C; Laguna, M; Testemale, D | 1 |
| Bergamini, P; Cortesi, R; Damiani, C; Drechsler, M; Esposito, E; Mariani, P; Marvelli, L; Pagnoni, A; Ravani, L; Sforza, F | 1 |
| Gandin, V; Giorgetti, M; Marzano, C; Porchia, M; Tisato, F; Trenti, A; Trevisi, L; Zanusso, I | 1 |
| Plavec, J; Seršen, S; Šket, P; Turel, I | 1 |
| Alessio, E; Arcangeli, A; Balducci, G; Battistin, F; Messori, L; Pillozzi, S; Scaletti, F | 1 |
| Florek, M; Guedes da Silva, MF; Jaros, SW; Kirillov, AM; Pombeiro, AJ; Smoleński, P | 1 |
| Britvin, SN; Padkina, MV; Rumyantsev, AM; Zobnina, AE | 1 |
| Bergamini, P; Carducci, F; Cortesi, R; Drechsler, M; Esposito, E; Gallerani, E; Gavioli, R; Mariani, P; Marvelli, L; Sguizzato, M | 1 |
| Dyson, PJ; Lee, RFS; Menin, L; Patiny, L; Ratanaphan, A; Temboot, P | 1 |
| Badillo Patzmay, GV; Kwiecień, A; Lupidi, G; Nabissi, M; Pettinari, C; Pettinari, R; Santoni, G; Smoleński, P; Wołoszyn, A | 1 |
| Alberti, P; Avezza, F; Bravin, A; Cavaletti, G; Ceresa, C; Gandin, V; Monfrini, M; Nicolini, G; Pellei, M; Santini, C; Semperboni, S | 1 |
| Nordlander, E; Quintero, MAS; Smith, GS; Stringer, T; Wiesner, L | 1 |
| Fadare, OA; Olasunkanmi, LO; Tabrizi, L | 1 |
| Atrián-Blasco, E; Cerrada, E; Faller, P; Hureau, C; Laguna, M | 1 |
| Burmeister, H; Kladnik, J; Kljun, J; Ott, I; Romero-Canelón, I; Turel, I | 1 |
| Gombos, R; Joó, F; Kathó, Á; Kováts, É; Papp, G; Szolnoki, CT; Udvardy, A | 1 |
| Bhilare, S; Kapdi, AR; Murthy Bandaru, SS; Schulzke, C | 1 |
| Shenderovich, IG | 1 |
| Błaszczyk, J; Kiełbasiński, P; Kwiatkowska, M; Sieroń, L | 1 |
1 review(s) available for 1,3,5-triaza-7-phosphaadamantane and adamantane
| Article | Year |
|---|---|
1,3,5-Triaza-7-phosphaadamantane (PTA) Derived Caged Phosphines for Palladium-Catalyzed Selective Functionalization of Nucleosides and Heteroarenes.
Topics: Adamantane; Aza Compounds; Catalysis; Coordination Complexes; Heterocyclic Compounds; Nucleosides; Organophosphorus Compounds; Palladium | 2021 |
42 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and adamantane
| Article | Year |
|---|---|
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Topics: Adamantane; Animals; Antineoplastic Agents; Benzene Derivatives; Buffers; Cell Line, Tumor; DNA; Female; Humans; Hydrolysis; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Sodium Chloride; Solutions; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2005 |
Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.
Topics: Adamantane; Animals; Cell Line, Tumor; Copper Radioisotopes; Female; Ligands; Mice; Mice, Inbred BALB C; Organophosphorus Compounds; Phosphines; Positron-Emission Tomography; Radiopharmaceuticals; Rats | 2008 |
Diastereomerically enriched analogues of the water-soluble phosphine PTA. Synthesis of phenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.1(3,7)]dec-6-yl)methanol (PZA) and the sulfide PZA(S) and X-ray crystal structures of the oxide PZA(O) and [Cp*IrCl(2)(PZA)]
Topics: Adamantane; Crystallography, X-Ray; Heterocyclic Compounds, 3-Ring; Iridium; Lithium; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Oxides; Phosphines; Salts; Solubility; Stereoisomerism; Sulfides; Water | 2008 |
Water-soluble and stable dinitrogen phosphine complexes trans-[ReCl(N2)(PTA-H)n(PTA)4-n]n+ (n = 0-4), the first with 1,3,5-triaza-7-phosphaadamantane.
Topics: Adamantane; Magnetic Resonance Spectroscopy; Molecular Structure; Nitrogen; Organometallic Compounds; Organophosphorus Compounds; Phosphines; Rhenium; Solubility; Stereoisomerism; Water | 2008 |
Synthesis, characterization, and in vitro cytotoxicity of some gold(I) and trans platinum(II) thionate complexes containing water-soluble PTA and DAPTA ligands. X-ray crystal structures of [Au(SC4H3N2)(PTA)], trans-[Pt(SC4H3N2)2(PTA)2], trans-[Pt(SC5H4N)2
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Gold; Humans; Ligands; Organometallic Compounds; Organophosphorus Compounds; Organoplatinum Compounds; Solubility; Structure-Activity Relationship | 2008 |
DNA structural distortions induced by ruthenium-arene anticancer compounds.
Topics: Adamantane; Antineoplastic Agents; Binding Sites; Calixarenes; Computer Simulation; DNA; Ethylenediamines; Guanine; Models, Chemical; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Stereoisomerism; Water | 2008 |
New water-soluble azido- and derived tetrazolato-platinum(II) complexes with PTA. Easy metal-mediated synthesis and isolation of 5-substituted tetrazoles.
Topics: Adamantane; Azides; Catalysis; Crystallography, X-Ray; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microwaves; Organometallic Compounds; Organophosphorus Compounds; Solubility; Spectrophotometry, Infrared; Tetrazoles; Water; Zinc | 2008 |
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Copper; Crystallography, X-Ray; Humans; Organophosphorus Compounds | 2009 |
Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
Topics: Adamantane; Antineoplastic Agents; Bridged Bicyclo Compounds; Cell Line, Tumor; Coordination Complexes; Glutathione Reductase; Gold; Humans; Ligands; Organophosphorus Compounds; Phosphines; Sulfonic Acids; Thioredoxin-Disulfide Reductase | 2010 |
Excellent correlation between cathepsin B inhibition and cytotoxicity for a series of palladacycles.
Topics: Adamantane; Cathepsin B; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Ferrous Compounds; Humans; Metallocenes; Molecular Conformation; Organophosphorus Compounds; Palladium; Phosphines | 2009 |
Electronic and geometric effects of phosphatriazaadamantane ligands on the catalytic activity of an [FeFe] hydrogenase inspired complex.
Topics: Adamantane; Catalysis; Crystallography, X-Ray; Electrochemistry; Hydrogenase; Iron-Sulfur Proteins; Ligands; Models, Molecular; Molecular Structure; Organophosphorus Compounds; Oxidation-Reduction | 2010 |
Synthesis, structures and in vitro cytotoxicity of some cationic cis-platinum(II) complexes containing chelating thiocarbamates.
Topics: Adamantane; Antineoplastic Agents; Cations, Divalent; Chelating Agents; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Organophosphorus Compounds; Organoplatinum Compounds; Piperazines; Pyridines; Stereoisomerism; Thiocarbamates; Tumor Cells, Cultured | 2011 |
Water-soluble Cp ruthenium complex containing 1,3,5-triaza-7-phosphaadamantane and 8-thiotheophylline derivatives: synthesis, characterization, and antiproliferative activity.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Crystallography, X-Ray; Humans; Models, Molecular; Neoplasms; Organophosphorus Compounds; Ruthenium Compounds; Solubility; Theophylline; Water | 2011 |
The Suzuki reaction in aqueous media promoted by P, N ligands.
Topics: Adamantane; Boronic Acids; Bromides; Catalysis; Chemistry, Organic; Crystallography, X-Ray; Insecticides; Ligands; Nitrogen; Organophosphorus Compounds; Palladium; Phosphines; Phosphorus; Solubility; Water | 2011 |
Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes.
Topics: Adamantane; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Candida albicans; Candidiasis; Cattle; Cell Line, Tumor; Chemistry, Pharmaceutical; Crystallography, X-Ray; Disinfectants; DNA; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Magnetic Resonance Spectroscopy; Melanoma; Mesylates; Microbial Sensitivity Tests; Models, Molecular; Organometallic Compounds; Organophosphorus Compounds; Silver Compounds; Spectrometry, Mass, Electrospray Ionization | 2011 |
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors.
Topics: Adamantane; Animals; Cell Line; Cell Proliferation; Cricetinae; DNA; Genetic Vectors; Humans; K562 Cells; Nanoparticles; Organophosphorus Compounds; Particle Size; Surface Properties; Transfection; Triglycerides | 2012 |
Hemilabile β-aminophosphine ligands derived from 1,3,5-triaza-7-phosphaadamantane: application in aqueous ruthenium catalyzed nitrile hydration.
Topics: Adamantane; Catalysis; Ligands; Models, Molecular; Molecular Structure; Nitriles; Organometallic Compounds; Organophosphorus Compounds; Phosphines; Ruthenium; Water | 2013 |
New water-soluble polypyridine silver(I) derivatives of 1,3,5-triaza-7-phosphaadamantane (PTA) with significant antimicrobial and antiproliferative activities.
Topics: Adamantane; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Candida albicans; Cell Line, Tumor; Cell Proliferation; DNA; Humans; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Pyridines; Silver; Solubility; Water | 2013 |
Oxorhenium complexes bearing the water-soluble tris(pyrazol-1-yl)methanesulfonate, 1,3,5-triaza-7-phosphaadamantane, or related ligands, as catalysts for Baeyer-Villiger oxidation of ketones.
Topics: Adamantane; Catalysis; Coordination Complexes; Ketones; Ligands; Mesylates; Organophosphorus Compounds; Oxidation-Reduction; Rhenium; Water | 2013 |
trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
Topics: Adamantane; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Palladium; Platinum; Solubility; Structure-Activity Relationship; Sulfhydryl Compounds; Water | 2013 |
Enhanced delivery of the RAPTA-C macromolecular chemotherapeutic by conjugation to degradable polymeric micelles.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cymenes; Drug Carriers; Drug Screening Assays, Antitumor; Endocytosis; Humans; Inhibitory Concentration 50; Micelles; Organometallic Compounds; Organophosphorus Compounds; Polymerization; Polymethacrylic Acids; Surface-Active Agents | 2013 |
Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
Topics: Adamantane; Alkylation; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Organogold Compounds; Organophosphorus Compounds; Phosphines; Structure-Activity Relationship | 2014 |
Acetylcholine-like and trimethylglycine-like PTA (1,3,5-triaza-7-phosphaadamantane) derivatives for the development of innovative Ru- and Pt-based therapeutic agents.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Platinum; Ruthenium; Structure-Activity Relationship | 2014 |
Syntheses, structures, and antimicrobial activity of new remarkably light-stable and water-soluble tris(pyrazolyl)methanesulfonate silver(I) derivatives of N-methyl-1,3,5-triaza-7-phosphaadamantane salt - [mPTA]BF4.
Topics: Adamantane; Adenosine Deaminase Inhibitors; Animals; Anti-Infective Agents; Bacteria; Candida albicans; Cattle; Chemistry Techniques, Synthetic; Drug Stability; Light; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Serum Albumin, Bovine; Silver; Solubility; Water | 2015 |
Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand.
Topics: Adamantane; Alzheimer Disease; Amyloid beta-Peptides; Copper; Humans; Organophosphorus Compounds; Oxidation-Reduction; Reactive Oxygen Species | 2015 |
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studies.
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; DNA; Humans; Lipids; Nanoparticles; Organophosphorus Compounds; Platinum | 2015 |
Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
Topics: Adamantane; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Copper; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Organophosphorus Compounds; Phosphines | 2015 |
Interactions of two cytotoxic organoruthenium(II) complexes with G-quadruplex.
Topics: Adamantane; Antineoplastic Agents; Binding Sites; Coordination Complexes; Crystallography, X-Ray; Cymenes; Deuterium; G-Quadruplexes; Magnetic Resonance Spectroscopy; Molecular Conformation; Monoterpenes; Nucleic Acid Denaturation; Organometallic Compounds; Organophosphorus Compounds; Ruthenium; Ultraviolet Rays | 2016 |
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
Topics: Adamantane; Antineoplastic Agents; Bromides; Cell Line, Tumor; Cell Survival; Chlorides; Coordination Complexes; Cytochromes c; Filaggrin Proteins; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Imidazoles; Indazoles; Inhibitory Concentration 50; Ligands; Oligonucleotides; Organometallic Compounds; Organophosphorus Compounds; Protons; Ribonuclease, Pancreatic; Ruthenium; Solubility; Structure-Activity Relationship; Water | 2016 |
Silver(I) 1,3,5-Triaza-7-phosphaadamantane Coordination Polymers Driven by Substituted Glutarate and Malonate Building Blocks: Self-Assembly Synthesis, Structural Features, and Antimicrobial Properties.
Topics: Adamantane; Anti-Infective Agents; Bacteria; Candida albicans; Coordination Complexes; Glutarates; Malonates; Microbial Sensitivity Tests; Organophosphorus Compounds; Polymers; Silver; Spectrum Analysis | 2016 |
Between Adamantane and Atrane: Intrabridgehead Interactions in the Cage-Like Phosphane Related to a Novel Tris(homoadamantane) Ring System.
Topics: Adamantane; Electrons; Ligands; Magnetic Resonance Spectroscopy; Methylation; Models, Molecular; Organophosphorus Compounds; Phosphines; Polycyclic Compounds; Solubility; Water | 2016 |
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (II) carboxylates.
Topics: Adamantane; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Carriers; Emulsions; Humans; K562 Cells; Lipids; Magnetic Resonance Spectroscopy; Nanoparticles; Organophosphorus Compounds; Particle Size; Platinum; Stearic Acids | 2017 |
Biochemical and biophysical characterization of ruthenation of BRCA1 RING protein by RAPTA complexes and its E3 ubiquitin ligase activity.
Topics: Adamantane; Binding Sites; BRCA1 Protein; Dose-Response Relationship, Drug; Humans; Molecular Structure; Organophosphorus Compounds; RING Finger Domains; Structure-Activity Relationship; Ubiquitin-Protein Ligases | 2017 |
Ru(ii)-(PTA) and -mPTA complexes with N
Topics: 2,2'-Dipyridyl; Adamantane; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Multiple Myeloma; Nitrogen; Organophosphorus Compounds; Phenanthrolines; Ruthenium | 2017 |
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)
Topics: Action Potentials; Adamantane; Animals; Antineoplastic Agents; Bortezomib; Carcinoma; Cell Line, Tumor; Cells, Cultured; Cisplatin; Copper; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Ganglia, Spinal; Gold; Humans; Mice; Mice, Inbred C57BL; Neuronal Outgrowth; Neurons; Organophosphorus Compounds; Peripheral Nerves; Polymerization; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tubulin | 2018 |
Evaluation of PTA-derived ruthenium(II) and iridium(III) quinoline complexes against chloroquine-sensitive and resistant strains of the Plasmodium falciparum malaria parasite.
Topics: Adamantane; Animals; Antimalarials; Chloroquine; Coordination Complexes; Drug Resistance; Iridium; Organophosphorus Compounds; Plasmodium falciparum; Quinolines; Ruthenium | 2019 |
Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various can
Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Cyclooxygenase Inhibitors; Drug Stability; HEK293 Cells; Humans; Ibuprofen; Ligands; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Naproxen; Organophosphorus Compounds; Reactive Oxygen Species; Ruthenium | 2019 |
Role of PTA in the prevention of Cu(amyloid-β) induced ROS formation and amyloid-β oligomerisation in the presence of Zn.
Topics: Adamantane; Alzheimer Disease; Amyloid beta-Peptides; Copper; Humans; Ligands; Organophosphorus Compounds; Protein Multimerization; Reactive Oxygen Species; Zinc | 2019 |
Towards Identification of Essential Structural Elements of Organoruthenium(II)-Pyrithionato Complexes for Anticancer Activity.
Topics: Adamantane; Antineoplastic Agents; Apoptosis; Coordination Complexes; Drug Screening Assays, Antitumor; Humans; Organophosphorus Compounds; Pyridines; Ruthenium; Thiones; Wound Healing | 2019 |
Mechanochemical P-derivatization of 1,3,5-Triaza-7-Phosphaadamantane (PTA) and Silver-Based Coordination Polymers Obtained from the Resulting Phosphabetaines.
Topics: Adamantane; Anti-Infective Agents; Betaine; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Conformation; Organophosphorus Compounds; Polymers; Silver | 2020 |
1,3,5-Triaza-7-Phosphaadamantane (PTA) as a
Topics: Adamantane; Catalysis; Coordination Complexes; Magnetic Resonance Spectroscopy; Molecular Probes; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Phosphorus; Transition Elements; Water | 2021 |
Enzymatic Approach to the Synthesis of Enantiomerically Pure Hydroxy Derivatives of 1,3,5-Triaza-7-phosphaadamantane.
Topics: Adamantane; Organometallic Compounds; Organophosphorus Compounds; Solubility; Water | 2021 |